These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes. Orzeck EA; Shi N; Blumentals WA Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482 [TBL] [Abstract][Full Text] [Related]
5. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study. Blumentals WA; Schulman KL Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of influenza A virus by oseltamivir in bone marrow transplant recipients. Mellouli F; Ouederni M; Dhouib N; Hajkacem MA; Slim A; Bejaoui M Pediatr Transplant; 2010 Mar; 14(2):178-81. PubMed ID: 19170930 [TBL] [Abstract][Full Text] [Related]
7. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Siedler K; Skopnik H Pediatr Infect Dis J; 2010 Jun; 29(6):495-8. PubMed ID: 20035245 [TBL] [Abstract][Full Text] [Related]
8. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population]. Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558 [TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of influenza infections in lung transplant recipients: a single-season cohort study. Schuurmans MM; Isenring BD; Jungo C; Boeni J; Mueller NJ; Kohler M; Benden C Transpl Infect Dis; 2014 Jun; 16(3):430-9. PubMed ID: 24810480 [TBL] [Abstract][Full Text] [Related]
10. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Smith JR; Sacks S Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756 [TBL] [Abstract][Full Text] [Related]
12. H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving. Suyani E; Aki Z; Güzel Ö; Altindal S; Senol E; Sucak G Transpl Infect Dis; 2011 Apr; 13(2):208-12. PubMed ID: 21214698 [TBL] [Abstract][Full Text] [Related]
13. [A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients]. Deng WW; Li QY; Zhong NS; Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2132-6. PubMed ID: 15730636 [TBL] [Abstract][Full Text] [Related]
14. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Kaiser L; Wat C; Mills T; Mahoney P; Ward P; Hayden F Arch Intern Med; 2003 Jul; 163(14):1667-72. PubMed ID: 12885681 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202 [TBL] [Abstract][Full Text] [Related]
16. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Machado CM; Boas LS; Mendes AV; da Rocha IF; Sturaro D; Dulley FL; Pannuti CS Bone Marrow Transplant; 2004 Jul; 34(2):111-4. PubMed ID: 15094755 [TBL] [Abstract][Full Text] [Related]
17. Pandemic influenza (H1N1): impact on lung transplant recipients and candidates. Fox BD; Raviv Y; Rozengarten D; Rusanov V; Bakal I; Kramer MR J Heart Lung Transplant; 2010 Sep; 29(9):1034-8. PubMed ID: 20558087 [TBL] [Abstract][Full Text] [Related]